Amphastar P (AMPH) financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $1.1B

Amphastar P reported revenue of $720M in fiscal 2025, up 12.2% a year over 9 years.

Net income was $98M and the operating margin 19.5%, against 6.0% in 2016.

Free cash flow was $121M, and the company returned $76M in net buybacks.

Revenue and free cash flow

Fiscal years, $ billions.

-0.200.20.40.60.82016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Amphastar P's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$255M$240M$295M$322M$350M$438M$499M$644M$732M$720M
Cost of revenue$151M$150M$188M$190M$207M$238M$250M$293M$358M$364M
Gross profit$104M$91M$107M$132M$143M$200M$249M$351M$374M$356M
Research and development$42M$44M$58M$69M$67M$61M$75M$74M$74M$86M
Selling, general and admin$47M$51M$58M$63M$65M$69M$67M$80M$95M$130M
Operating income$15M-$1M-$9M-$39,000$11M$70M$107M$197M$205M$140M
Interest expense$1M$826,000$243,000$119,000$374,000$885,000$2M$27M$30M$25M
Pre-tax income$15M$1M-$10M$60M$5M$84M$116M$171M$190M$124M
Income tax$5M-$2M-$3M$14M$4M$21M$23M$32M$30M$26M
Net income$10M$4M-$6M$49M$1M$62M$91M$138M$160M$98M
EPS (diluted)$0.21$0.08-$0.12$0.98$0.03$1.25$1.74$2.60$3.06$2.03
Diluted shares48M48M46M50M49M50M52M53M52M48M
Gross margin40.8%37.7%36.3%40.9%41.0%45.6%49.9%54.5%51.1%49.5%
Operating margin6.0%-0.5%-2.9%-0.0%3.1%16.0%21.5%30.6%28.1%19.5%
Net margin3.8%1.5%-1.9%15.2%0.4%14.2%18.3%21.3%21.8%13.6%

Balance sheet

Fiscal years, from Amphastar P's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$73M$68M$89M$85M$106M$137M$176M$257M$222M$283M
Receivables$27M$36M$52M$45M$66M$79M$89M$115M$136M$144M
Inventory$80M$64M$69M$111M$97M$93M$104M$106M$154M$177M
Total current assets$184M$188M$220M$255M$280M$318M$378M$490M$534M$636M
Property, plant and equipment$153M$181M$210M$234M$260M$244M$238M$283M$297M$311M
Goodwill$4M$4M$4M$4M$4M$3M$3M$3M$3M$3M
Total assets$428M$451M$514M$587M$631M$672M$742M$1.5B$1.6B$1.6B
Total current liabilities$61M$67M$107M$90M$112M$104M$95M$225M$174M$158M
Long-term debt$32M$41M$32M$39M$34M$75M$73M$590M$602M$609M
Total liabilities$98M$117M$149M$159M$183M$226M$213M$873M$845M$840M
Shareholders' equity$329M$334M$332M$381M$402M$446M$529M$639M$732M$789M
Net debt-$40M-$25M-$54M-$34M-$58M-$52M-$83M$445M$450M$439M

Cash flow

Fiscal years, from Amphastar P's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow$39M$39M$38M$42M$57M$98M$89M$184M$213M$156M
Capital spending$21M$35M$47M$42M$34M$27M$24M$38M$41M$35M
Free cash flow$17M$4M-$9M$207,000$23M$71M$65M$145M$172M$121M
Stock-based compensation$15M$17M$17M$17M$20M$19M$18M$20M$24M$27M
Share buybacks (net)-$10M-$31M-$25M-$22M-$24M-$29M-$40M-$58M-$85M-$76M
Net borrowing-$4M$9M$3M-$3M-$2M$33M-$2M$526M-$8M-$223,000
Free cash flow margin6.7%1.7%-2.9%0.1%6.7%16.1%13.1%22.6%23.5%16.8%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AMPH.
Open AMPH in Investingly

Questions

What was Amphastar P's revenue in 2025?

$720M in fiscal 2025, from its 10-K filing.

How much free cash flow does Amphastar P generate?

$121M in fiscal 2025 (operating cash flow minus capital spending).

From Amphastar P's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.